Unlocking Opportunities in the Monoclonal Antibodies In Veterinary Health Market: Key Trends, Market Growth, and Forecast Insights
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Factors Are Propelling the Market Growth of theMonoclonal Antibodies In Veterinary Health Market from 2025 to 2034?
The growth of the monoclonal antibodies in the veterinary health market is projected to be propelled by increasing instances of animal diseases. The surge in animal diseases is fueled by heightened farming practices, leading to a higher risk of infectious disease transmission, and alterations in climate, broadening the habitat of disease carriers like ticks and mosquitos. Monoclonal antibodies are beneficial in combatting animal diseases as they aim at specific pathogens or proteins involved in the disease’s manifestation, providing accurate and effective remedies. For example, a report by GOV.UK, a government website based in the UK, revealed that the number of animals culled due to TB attacks increased by 5% in England, reaching 21, 298, and by 17% in Wales, reaching 11,197 between April 2023 and March 2024. These growing instances of animal diseases contribute to the expansion of the monoclonal antibodies in the veterinary health market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20575&type=smp
How Has the Monoclonal Antibodies In Veterinary Health Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?
The market size of monoclonal antibodies in veterinary health has seen a swift expansion in recent times. It is projected to expand from $0.8 billion in 2024 to $0.92 billion in 2025, boasting a compound annual growth rate (CAGR) of 15.2%. Factors like the surge in worldwide pet ownership, rising instances of chronic diseases in animals, growing pet adoption rates, and heightened health awareness among pet owners contributed to the growth recorded in the historic period.
Expectations for the monoclonal antibodies in the veterinary health market size suggest swift expansion in the upcoming years. By 2029, it is projected to have risen to $1.61 billion, with a compound annual growth rate (CAGR) of 15.0%. The anticipated growth in the forecasted period is tied to factors such as an escalating pet population, increased spending on pets, intensified occurrences of canine atopic dermatitis, surging demand for superior veterinary healthcare, and heightened awareness of animal health. The forecasted period also anticipates key trends including breakthroughs in biotechnological research, genetic engineering enhancements, inventive treatments, advancements in therapeutic antibodies, and technological progress in antibody engineering.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20575
How Are Market Trends and Innovations Revolutionizing theMonoclonal Antibodies In Veterinary Health Industry in Recent Times?
Leading corporations within the monoclonal antibodies in veterinary health market are directing their efforts to create inventive veterinary therapeutic options, like anti-NGF monoclonal antibody therapies, which aim to alleviate chronic pain and inflammation in animals. The anti-NGF therapy works by targeting and suppressing nerve growth factor (NGF) which in turn, reduces pain and inflammation in animals with chronic pain. For example, Zoetis, a US-based animal health firm, secured FDA approval in May 2023 for Librela (bedinvetmab injection), marking it as the first monoclonal antibody therapy designed for pain management in osteoarthritic dogs. It is provided through a monthly injection. Additionally, they introduced Apoquel Chewable, the first chewable drug designed specifically for controlling allergic itch and inflammation in dogs aged over a year. Librela is an antibody that restricts and suppresses NGF and by blocking NGF, it inhibits pain signals from reaching the brain thus, reducing pain in canines suffering from osteoarthritis. It signifies a key progression in veterinary pain management, offering a novel method for addressing chronic pain in canines.
Which Key Market Players Are Shaping the Future and Growth of theMonoclonal Antibodies In Veterinary Health Market?
Major companies operating in the monoclonal antibodies in veterinary health market are Sanofi S.A., Bristol-Myers Squibb Company, GlaxoSmithKline plc (GSK), Amgen Inc., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Zoetis Inc., MSD Animal Health, Elanco Animal Health Incorporated, Bio-Rad Laboratories Inc., Eli Lilly and Company, GenScript Biotech Corporation, Abcam plc, Heska Corporation, Neogen Corporation, iNova Pharmaceuticals, Ceva Santé Animale S.A., Biogénesis Bagó S.A., TransGen Biotech Co. Ltd., AbCellera Biologics Inc., Areteia Therapeutics Inc., Esco Aster Pte Ltd, PetMedix Ltd., Vaxine Pty Ltd
Order Your Report Now For A Swift Delivery:
What Are the Core Segments of the Monoclonal Antibodies In Veterinary Health Market, and How Do They Contribute to Growth?
The monoclonal antibodies in veterinary health market covered in this report is segmented –
1) By Animal Type: Dogs, Other Animal Types
2) By Application: Dermatology, Pain, Other Applications
3) By End-User: Veterinary Hospitals, Other End-Users
Subsegments:
1) By Dogs: Canine Infectious Diseases, Canine Cancer Treatment, Canine Autoimmune Disorders, Canine Allergies
2) By Other Animal Types: Cats, Horses, Cattle, Swine, Poultry, Aquatic Animals, Small Mammals
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=20575&type=smp
What Regions Are Dominating the Monoclonal Antibodies In Veterinary Health Market Growth?
North America was the largest region in the monoclonal antibodies in veterinary health market in 2024. The regions covered in the monoclonal antibodies in veterinary health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Monoclonal Antibodies In Veterinary Health Market 2025, By The Business Research Company:
Veterinary Pain Management Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report
Veterinary Reference Laboratory Global Market Report 2025
Veterinary Radiosurgery System Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
